PCA3 in prostate cancer and tumor aggressiveness detection on 407 high-risk patients: a National Cancer Institute experience.
Merola R, Tomao L, Antenucci A, Sperduti I, Sentinelli S, Masi S, Mandoj C, Orlandi G, Papalia R, Guaglianone S, Costantini M, Cusumano G, Cigliana G, Ascenzi P, Gallucci M, Conti L.
Merola R, et al. Among authors: conti l.
J Exp Clin Cancer Res. 2015 Feb 6;34(1):15. doi: 10.1186/s13046-015-0127-8.
J Exp Clin Cancer Res. 2015.
PMID: 25651917
Free PMC article.